At the time, Thompson was director of the Abramson Cancer Center at the University of Pennsylvania, and as a medical oncologist with training in immunology, he was studying normal,
healthy white blood cells, or lymphocytes, to understand how fast - dividing cells make the decision to divide.
As more cancer cells are produced, they stop
the healthy white blood cells from growing and functioning normally, by crowding out space in the blood.